GC62338
GSK-3β inhibitor 3
Also known as 2-(4-fluorophenyl)-5-prop-2-enoyl-2,3-dihydro-1,5-benzothiazepin-4-one
GSK-3β inhibitor 3 is a potent, selective, irreversible and covalent inhibitor of Glycogen Synthase Kinase 3β (GSK-3β), with an IC50 of 6·6 μM· GSK-3β inhibitor 3 can be used for the research of acute promyelocytic leukemia
ChemicalCAS1448990-73-5MW327.37FormulaC18H14FNO2S
- CAS number
- 1448990-73-5
- Molecular weight
- 327.37
- Formula
- C18H14FNO2S
- Solubility
- DMSO ： 250 mg/mL (763·66 mM; Need ultrasonic)
- InChIKey
- DJUQPBPAHPCBBX-UHFFFAOYSA-N
- Catalogue number
- GC62338
- Brand
- GLPBIO
Computed properties PubChem CID 155925848 · XLogP 3.5 · TPSA 62.7 Ų · H-bond donors 0
- XLogP
- 3.5
- TPSA
- 62.7 Ų
- H-bond donors
- 0
- H-bond acceptors
- 4
- Rotatable bonds
- 2
- Heavy atoms
- 23
SMILES C=CC(=O)N1C(=O)CC(SC2=CC=CC=C21)C3=CC=C(C=C3)F
Computed descriptors from PubChem (CID 155925848), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il